We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-14.49%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$183B
AUM Growth
-$41.5B
Cap. Flow
-$8B
Cap. Flow %
-4.38%
Top 10 Hldgs %
23.66%
Holding
10,385
New
1,237
Increased
3,761
Reduced
3,800
Closed
1,371

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$783M
2
MS icon
Morgan Stanley
MS
+$518M
3
LOW icon
Lowe's Companies
LOW
+$474M
4
V icon
Visa
V
+$425M
5
NFLX icon
Netflix
NFLX
+$419M

Sector Composition

Rank Sector Weight
1 Financials 5.01%
2 Technology 4.76%
3 Consumer Discretionary 3.82%
4 Industrials 3.81%
5 Communication Services 3.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SONN
8501
DELISTED
Sonnet BioTherapeutics
SONN
0
TOPS icon
8502
TOP Ships
TOPS
$4.88M
0
NYMX
8503
CALL
DELISTED
Nymox Pharmaceutical Corp
NYMX
$26K ﹤0.01%
+20,200
New +$37K
REED
8504
DELISTED
Reeds, Inc. Common Stock
REED
$26K ﹤0.01%
+247
New +$30.9K
AHPI
8505
DELISTED
Allied Healthcare Products
AHPI
$26K ﹤0.01%
13,154
+1,056
+9% +$2.13K
LGCY
8506
DELISTED
Legacy Reserves Inc. Common Stock
LGCY
$26K ﹤0.01%
16,776
+4,161
+33% +$13.3K
AIM
8507
AIM ImmunoTech
AIM
$6.1M
$26K ﹤0.01%
32
+8
+33% +$7.34K
FCEL icon
8508
CALL
FuelCell Energy
FCEL
$1.79B
$25K ﹤0.01%
126
-52
-29% -$14.9K
LPTH icon
8509
Lightpath Technologies
LPTH
$953M
$25K ﹤0.01%
+16,476
New +$29.1K
ORIO
8510
Orion Digital Corp
ORIO
$20.2M
$25K ﹤0.01%
3,633
+156
+4% +$1.26K
MVIS icon
8511
Microvision
MVIS
$53M
$25K ﹤0.01%
2,711
-435
-14% -$6.12K
REPX icon
8512
Riley Exploration Permian
REPX
$800M
$25K ﹤0.01%
+2,193
New +$27.6K
VGZ icon
8513
Vista Gold
VGZ
$337M
$25K ﹤0.01%
46,927
+23,717
+102% +$12.2K
QCLS
8514
Q/C Technologies Inc
QCLS
$21.8M
0
NYMX
8515
DELISTED
Nymox Pharmaceutical Corp
NYMX
$25K ﹤0.01%
19,158
-16,308
-46% -$29.9K
GSUM
8516
DELISTED
Gridsum Holding Inc.
GSUM
$25K ﹤0.01%
+11,054
New +$51.9K
FRAN
8517
PUT
DELISTED
Francesca's Holdings Corporation
FRAN
$25K ﹤0.01%
2,183
-4,367
-67% -$127K
AKAO
8518
CALL
DELISTED
Achaogen Inc
AKAO
$25K ﹤0.01%
20,500
-114,200
-85% -$305K
PHIIK
8519
DELISTED
PHI, Inc. Non-Voting Common Stock
PHIIK
$25K ﹤0.01%
+13,488
New +$78.1K
SBET icon
8520
Sharplink Inc
SBET
$1.36B
$24K ﹤0.01%
+56
New +$22.8K
SEEL
8521
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$24K ﹤0.01%
+1
New +$34.7K
DMK
8522
CALL
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$24K ﹤0.01%
154
-600
-80% -$115K
CHKR
8523
DELISTED
CHESAPEAKE GRANITE WASH TRUST
CHKR
$24K ﹤0.01%
+21,377
New +$31.7K
FWP
8524
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$24K ﹤0.01%
+4,393
New +$44.3K
TISA
8525
DELISTED
TOP Image Systems Ltd
TISA
$24K ﹤0.01%
48,902
+38,823
+385% +$29.1K

Similar funds

Citadel Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, Citadel Advisors held 10,385 positions worth $183B, down 19% from $224B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Citadel Advisors withdrew a net $8B in Q4 2018, closing 1,371 positions and reducing 3,800 holdings. Its most notable exit was Aetna Inc, an estimated $783M position sold in full.

By sector, the portfolio is most concentrated in Financials at 5% of assets, down from 5.9% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Citadel Advisors opened a new position in Assurant worth $99.4M.

  • Citadel Advisors's largest Q4 2018 buy was Assurant: 1,111,342 shares worth $99.4M.
  • Citadel Advisors added most to Amazon in Q4 2018, an estimated $1.68B increase.
  • Citadel Advisors's biggest Q4 2018 reduction was Morgan Stanley, cutting an estimated $518M.
  • Citadel Advisors fully exited Aetna Inc in Q4 2018, selling an estimated $783M.
  • Citadel Advisors's ten largest holdings make up 24% of its $183B portfolio in Q4 2018.
  • Citadel Advisors opened 1,237 new positions and closed 1,371 in Q4 2018.
  • Citadel Advisors's portfolio value fell 19% quarter-over-quarter to $183B.

Based on Citadel Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.